Cargando…

Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis

PURPOSE: Multiple sclerosis (MS) is the most neurologic disease among individuals of 20–45 years. About 75% of MS patients report bladder problems that have a moderate-high impact on their life. The present study aimed to translate and determine the validity and reliability of the Persian version of...

Descripción completa

Detalles Bibliográficos
Autores principales: Azadvari, Mohaddeseh, Naser Moghadasi, Abdorreza, Azimi, Amir Reza, Sharifiaghdas, Farzaneh, Emami Razavi, Seyede Zahra, Eskandarieh, Sharareh, Hosseini, Maryam, Rahimi-Dehgolan, Shahram, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974412/
https://www.ncbi.nlm.nih.gov/pubmed/32021237
http://dx.doi.org/10.2147/JMDH.S236275
_version_ 1783490089299476480
author Azadvari, Mohaddeseh
Naser Moghadasi, Abdorreza
Azimi, Amir Reza
Sharifiaghdas, Farzaneh
Emami Razavi, Seyede Zahra
Eskandarieh, Sharareh
Hosseini, Maryam
Rahimi-Dehgolan, Shahram
Sahraian, Mohammad Ali
author_facet Azadvari, Mohaddeseh
Naser Moghadasi, Abdorreza
Azimi, Amir Reza
Sharifiaghdas, Farzaneh
Emami Razavi, Seyede Zahra
Eskandarieh, Sharareh
Hosseini, Maryam
Rahimi-Dehgolan, Shahram
Sahraian, Mohammad Ali
author_sort Azadvari, Mohaddeseh
collection PubMed
description PURPOSE: Multiple sclerosis (MS) is the most neurologic disease among individuals of 20–45 years. About 75% of MS patients report bladder problems that have a moderate-high impact on their life. The present study aimed to translate and determine the validity and reliability of the Persian version of ABSST questionnaire. METHODS: The standard validation process for preparing the Persian version of ABSST was performed by means of an expert committee. After a pilot study and confirming the harmonized translated form, we tested the final version of questionnaire on 40 patients with a definite diagnosis of MS symptoms, once at the baseline and another after two weeks in order to prevent recall-induced agreement. Test-retest reliability was calculated as Spearman's correlation coefficient. Also, content validity indices (CVIs), as well as internal consistency were analyzed in STATA. RESULTS: Forty participants with a mean age of 38.8 years were included in this study. Only 20% of them were male. The Persian version achieved a good internal consistency with a Cronbach-α value of 0.91, relatively similar to the original version. The coefficients for measuring the correlation between each item score with the total score of our questionnaire were between 0.58–0.89. This value confirmed an appropriate validity for the Persian version of ABSST. Regarding test-retest reliability assessment, total Spearman`s coefficient was 0.85; with 0.84 for the severity of symptoms and 0.87 for the impact of urologic disorders on patients` social life. CONCLUSION: The current findings proved that this accurate questionnaire could be used to investigate urinary symptoms among Persian-speaking MS patients.
format Online
Article
Text
id pubmed-6974412
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69744122020-02-04 Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis Azadvari, Mohaddeseh Naser Moghadasi, Abdorreza Azimi, Amir Reza Sharifiaghdas, Farzaneh Emami Razavi, Seyede Zahra Eskandarieh, Sharareh Hosseini, Maryam Rahimi-Dehgolan, Shahram Sahraian, Mohammad Ali J Multidiscip Healthc Original Research PURPOSE: Multiple sclerosis (MS) is the most neurologic disease among individuals of 20–45 years. About 75% of MS patients report bladder problems that have a moderate-high impact on their life. The present study aimed to translate and determine the validity and reliability of the Persian version of ABSST questionnaire. METHODS: The standard validation process for preparing the Persian version of ABSST was performed by means of an expert committee. After a pilot study and confirming the harmonized translated form, we tested the final version of questionnaire on 40 patients with a definite diagnosis of MS symptoms, once at the baseline and another after two weeks in order to prevent recall-induced agreement. Test-retest reliability was calculated as Spearman's correlation coefficient. Also, content validity indices (CVIs), as well as internal consistency were analyzed in STATA. RESULTS: Forty participants with a mean age of 38.8 years were included in this study. Only 20% of them were male. The Persian version achieved a good internal consistency with a Cronbach-α value of 0.91, relatively similar to the original version. The coefficients for measuring the correlation between each item score with the total score of our questionnaire were between 0.58–0.89. This value confirmed an appropriate validity for the Persian version of ABSST. Regarding test-retest reliability assessment, total Spearman`s coefficient was 0.85; with 0.84 for the severity of symptoms and 0.87 for the impact of urologic disorders on patients` social life. CONCLUSION: The current findings proved that this accurate questionnaire could be used to investigate urinary symptoms among Persian-speaking MS patients. Dove 2020-01-17 /pmc/articles/PMC6974412/ /pubmed/32021237 http://dx.doi.org/10.2147/JMDH.S236275 Text en © 2020 Azadvari et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Azadvari, Mohaddeseh
Naser Moghadasi, Abdorreza
Azimi, Amir Reza
Sharifiaghdas, Farzaneh
Emami Razavi, Seyede Zahra
Eskandarieh, Sharareh
Hosseini, Maryam
Rahimi-Dehgolan, Shahram
Sahraian, Mohammad Ali
Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
title Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
title_full Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
title_fullStr Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
title_full_unstemmed Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
title_short Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
title_sort persian adaptation of actionable bladder symptom screening tool among patients with multiple sclerosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974412/
https://www.ncbi.nlm.nih.gov/pubmed/32021237
http://dx.doi.org/10.2147/JMDH.S236275
work_keys_str_mv AT azadvarimohaddeseh persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT nasermoghadasiabdorreza persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT azimiamirreza persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT sharifiaghdasfarzaneh persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT emamirazaviseyedezahra persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT eskandariehsharareh persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT hosseinimaryam persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT rahimidehgolanshahram persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis
AT sahraianmohammadali persianadaptationofactionablebladdersymptomscreeningtoolamongpatientswithmultiplesclerosis